Clinical trial
CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas
NCT00074243 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00074243 |
|---|---|
| Title | CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas |
| Official title | A Phase I Trial Of CC-8490 For The Treatment Of Patients With Recurrent/Refractory High-Grade Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | CC-8490 |
| Start date | Dec 1, 2003 |
| First posted | Dec 11, 2003 |
| Last update posted | Apr 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: